Sage Journals: Discover world-class research

Retricted access

Research article

First published 1991-6

Synthetic Polymers Conjugated to Monoclonal Antibodies: Vehicles for Tumour-Targeted Drug Delivery

Len W. Seymour, Pauline A. Flanagan, Aymen Al-Shamkhani [...]

Cancer Biotherapy and Radiopharmaceuticals

Retricted access

Research article

First published 2019-2

Antibody drug conjugates: Progress,pitfalls,and promises

Anubhab Mukherjee, Ariana K. Waters, Ivan Babic [...]

Human Antibodies

Open access

Research article

First published 2026

Gastrointestinal adverse events following brentuximab vedotin and polatuzumab vedotin therapy

Andrew G. Kuang, Malek Shatila, Jay S. Shah [...]

Therapeutic Advances in Medical Oncology

Open access

Review article

First published 2026

Focusing on the Advances and Challenges of HER2-Targeted Therapy: Cutting-Edge Breakthroughs in Neoadjuvant Treatment for HER2-Positive Breast Cancer

Anqi Shang, Yunjing Xiong, Min Li [...]

Technology in Cancer Research & Treatment

Open access

Review article

First published 2021

Oncogenic mechanism-based pharmaceutical validation of therapeutics targeting MET receptor tyrosine kinase

Hang-Ping Yao, Xiang-Min Tong, Ming-Hai Wang

Therapeutic Advances in Medical Oncology

Retricted access

Review article

First published 2024-8

Antibody drug conjugates: Design implications for clinicians

Stephanie Pang, Arianne Duong, Chloe Siu [...]

Journal of Oncology Pharmacy Practice

Open access

Research article

First published 2026-3

Clinical application and optimization strategies for antibody–drug conjugates in solid tumors

Jie Qu, Xiaoyue Zhao, Linzhu Zhang [...]

Journal of International Medical Research

Retricted access

Research article

First published 2018-2

Cloning and molecular characterization of the cDNAs encoding the variable regions of an anti-CD20 monoclonal antibody

Dariush Shanehbandi, Jafar Majidi, Tohid Kazemi [...]

Human Antibodies

Free access

Research article

First published 2005-8

Cancer Therapy with Radiolabeled and Drug/Toxin-conjugated Antibodies

Serengulam V. Govindan, Gary L. Griffiths, Hans J. Hansen [...]

Technology in Cancer Research & Treatment

Open access

Review article

First published 2012

Emerging Pharmacotherapy for Relapsed or Refractory Hodgkins Lymphoma: Focus on Brentuximab Vedotin

Michelle Furtado, Simon Rule

Clinical Medicine Insights: Oncology

Search results